0000105770-24-000071.txt : 20241007 0000105770-24-000071.hdr.sgml : 20241007 20241007160441 ACCESSION NUMBER: 0000105770-24-000071 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241001 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241007 DATE AS OF CHANGE: 20241007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 241357814 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 wst-20241001.htm 8-K wst-20241001
0000105770false00001057702024-10-012024-10-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) – October 1, 2024
wstlogoq319.jpg
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
1-8036
23-1210010
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
530 Herman O. West Drive, Exton, PA
19341-1147
(Address of principal executive offices)
(Zip Code)
 Registrant’s telephone number, including area code: 610-594-2900
Not Applicable
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.25 per shareWSTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 1, 2024, Silji Abraham, Senior Vice President & Chief Technology Officer of West Pharmaceutical Services, Inc. (the “Company”), notified the Company that he intends to resign, effective December 31, 2024, to pursue other interests. The Company will work with Mr. Abraham and his leadership team to ensure a smooth transition of his duties prior to his departure. Mr. Abraham’s departure is not the result of any disagreement with the Company on matters related to operations, policies or practices, and he will receive no additional compensation as a result of his departure.



Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit No.
Description
104
The cover page from the Company’s Current Report on Form 8-K, dated October 1, 2024, formatted in Inline XBRL.



2




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: October 7, 2024
WEST PHARMACEUTICAL SERVICES, INC.
By:
/s/ Kimberly Banks MacKay
Kimberly Banks MacKay
Senior Vice President, General Counsel and Secretary



3





EXHIBIT INDEX

Exhibit No.
Description
104
The cover page from the Company’s Current Report on Form 8-K, dated October 1, 2024, formatted in Inline XBRL.

4
 EX-101.SCH 2 wst-20241001.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 wst-20241001_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cover [Abstract] Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security City Area Code City Area Code Document Period End Date Document Period End Date Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 wst-20241001_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 5 wst-20241001_g1.jpg GRAPHIC begin 644 wst-20241001_g1.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover Page
Oct. 01, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Oct. 01, 2024
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity File Number 1-8036
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive
Entity Address, City or Town Exton
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-1147
City Area Code 610
Local Phone Number 594-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000105770
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G M%C:^?VZH: MTE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P M9:P!Q+MTFF6SU%L,9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<' M)O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:- MY&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_ M4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!DZV]@A=*'UE4PX!19W=U,5S MU %ORL'C:*R$"@.4;ZH5E=>2BBTGW='K3.\?)H]:1NO<2KGW\$JV''..?[3\ M 5!+ P04 " "4@$=9)!Z;HJT #X 0 &@ 'AL+U]R96QS+W=O[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD M3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\, M<'AT_@%02P,$% @ E(!'6660>9(9 0 SP, !, !;0V]N=&5N=%]4 M>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-. MVDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B M2K636Q#WR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9HS5* M$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I: MP'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$Y ML01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\; MSO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4 " "4@$=9!T%-8H$ "Q M $ @ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 M ( )2 1UF$N0(1[@ "L" 1 " :\ !D;V-0&UL4$L! A0#% @ E(!' M6>R\;?E6! D! !@ ("!#0@ 'AL+W=O*NQS M $P( L ( !=0\ %]R96QS+RYR96QS4$L! A0#% M @ E(!'61E%%?4W 0 )P( \ ( !7A 'AL+W=O7!E&UL4$L%!@ ) D /@( /$3 $! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.westpharma.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports wst-20241001.htm wst-20241001.xsd wst-20241001_lab.xml wst-20241001_pre.xml wst-20241001_g1.jpg http://xbrl.sec.gov/dei/2024 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "wst-20241001.htm": { "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20241001", "dts": { "inline": { "local": [ "wst-20241001.htm" ] }, "schema": { "local": [ "wst-20241001.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd" ] }, "labelLink": { "local": [ "wst-20241001_lab.xml" ] }, "presentationLink": { "local": [ "wst-20241001_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.westpharma.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20241001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "wst-20241001.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.westpharma.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000105770-24-000071-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-24-000071-xbrl.zip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end XML 16 wst-20241001_htm.xml IDEA: XBRL DOCUMENT 0000105770 2024-10-01 2024-10-01 0000105770 false 8-K 2024-10-01 WEST PHARMACEUTICAL SERVICES, INC. PA 1-8036 23-1210010 530 Herman O. West Drive Exton PA 19341-1147 610 594-2900 false false false false Common Stock, par value $0.25 per share WST NYSE false